DIETARY SUPPLEMENTATION WITH PECANS DELAYS MOTOR NEURON PATHOLOGY IN TRANSGENIC MICE EXPRESSING G93A MUTANT HUMAN SUPEROXIDE DISMUTASE-1

被引:1
|
作者
Suchy, James [1 ]
Lee, Sangmook [1 ]
Ahmed, Ambar [1 ]
Shea, Thomas B. [1 ]
机构
[1] Univ Massachusetts, Dept Biol Sci, Ctr Cellular Neurobiol & Neurodegenerat Res, Lowell, MA 01854 USA
关键词
Amyotropic Lateral Sclerosis; Ghosts; Motor Neuron Disease; Mouse Model; Neuromuscular Performance; Nutrition; Super Oxide Dismutase-1; AMYOTROPHIC-LATERAL-SCLEROSIS; CORONARY-HEART-DISEASE; OXIDATIVE STRESS; MOUSE MODEL; VITAMIN-E; CU; ZN-SUPEROXIDE DISMUTASE; BEHAVIORAL DEFICITS; PROLONGS SURVIVAL; ALZHEIMER-DISEASE; SYMPTOM ONSET;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
A growing body of evidence indicates that diet can modulate health in aging to the extent of delaying the manifestation of age-related diseases. Nuts are among the antioxidant-rich foods that have been demonstrated to provide a degree of protection against age-related disorders We examined herein whether or not dietary supplementation with pecans could affect the course of pathology in a mouse model of the age-related human motor neuron disorder amyotropic lateral sclerosis (ALS). Transgenic mice expressing the G93A mutation of human superoxide dismutase-1 SOD-1 have been widely utilized to study the onset and progression of familial ALS. Mice provided a diet supplemented with 0.05% pecans displayed a significant delay in decline in motor neuron Auction. which was accompanied by increased survival of motor neurons and a decrease in reactive gliosis, as compared to non-supplemented mice. These findings support inclusion of pecans and/or other nuts as part of a comprehensive nutritional therapeutic approach that may augment pharmacological approaches.
引用
收藏
页码:45 / 54
页数:10
相关论文
共 50 条
  • [1] Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu/Zn superoxide dismutase
    Alexander, GM
    Deitch, JS
    Seeburger, JL
    Del Valle, L
    Heiman-Patterson, TD
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 (04) : 1666 - 1673
  • [2] Phenotype of Transgenic Mice Carrying a Very Low Copy Number of the Mutant Human G93A Superoxide Dismutase-1 Gene Associated with Amyotrophic Lateral Sclerosis
    Deitch, Jeffrey S.
    Alexander, Guillermo M.
    Bensinger, Andrew
    Yang, Steven
    Jiang, Juliann T.
    Heiman-Patterson, Terry D.
    PLOS ONE, 2014, 9 (06):
  • [3] Increased proapoptotic protein levels in transgenic mice expressing mutant superoxide dismutase-1
    Vukosavic, S
    Neystat, M
    Jackson-Lewis, V
    Romero, N
    Przedborski, S
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 462 - 463
  • [4] Immunosuppressant FK506 does not exert beneficial effects in symptomatic G93A superoxide dismutase-1 transgenic mice
    Anneser, JMH
    Gmerek, A
    Gerkrath, J
    Borasio, GD
    Heumann, R
    NEUROREPORT, 2001, 12 (12) : 2663 - 2665
  • [5] Activation and response to axotomy of microglia in the facial motor nuclei of G93A superoxide dismutase transgenic mice
    Mariotti, R
    Bentivoglio, M
    NEUROSCIENCE LETTERS, 2000, 285 (02) : 87 - 90
  • [6] Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1
    Jonsson, P. Andreas
    Graffmo, Karin S.
    Brannstrom, Thomas
    Nilsson, Peter
    Andersen, Peter M.
    Marklund, Stefan L.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2006, 65 (12): : 1126 - 1136
  • [7] Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: Mechanisms of mitochondriopathy and cell death
    Martin, Lee J.
    Liu, Zhiping
    Chen, Kevin
    Price, Ann C.
    Pan, Yan
    Swaby, Jason A.
    Golden, W. Christopher
    JOURNAL OF COMPARATIVE NEUROLOGY, 2007, 500 (01) : 20 - 46
  • [8] Calcineurin A and calbindin immunoreactivity in the spinal cord of G93A superoxide dismutase transgenic mice
    Knirsch, U
    Sturm, S
    Reuter, A
    Bachus, R
    Gosztonyi, G
    Voelkel, H
    Ludolph, AC
    BRAIN RESEARCH, 2001, 889 (1-2) : 234 - 238
  • [9] Elevated cortical ECF glutamate in transgenic mice expressing human mutant (G93A) SOD1
    Alexander, GM
    Deitch, JS
    Seeburger, JL
    Israeli, DA
    Heiman-Patterson, TD
    NEUROLOGY, 1999, 52 (06) : A531 - A532
  • [10] Chemotherapy delays progression of motor neuron disease in the SOD1 G93A transgenic mouse
    Bruce, KM
    Narayan, K
    Kong, HC
    Larmour, I
    Lopes, EC
    Turner, BJ
    Bertram, JF
    Cheema, SS
    CHEMOTHERAPY, 2004, 50 (03) : 138 - 142